The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biosimilar Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biosimilar market size is estimated to be worth US$ 8650.9 million in 2021 and is forecast to a readjusted size of USD 22110 million by 2028 with a CAGR of 14.3% during review period. Hospital Pharmacy accounting for % of the Biosimilar global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biosimilar include AET BioTech, Amgen, Boehringer Ingelheim, Coherus Biosciences, and Fujifilm Kyowa Kirin Biologics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilar market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Oral Solution
Market segment by Application, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market segment by players, this report covers
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar, with revenue, gross margin and global market share of Biosimilar from 2019 to 2022.
Chapter 3, the Biosimilar competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilar market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilar research findings and conclusion, appendix and data source.
Geographical Area
Global
The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biosimilar market size is estimated to be worth US$ 8650.9 million in 2021 and is forecast to a readjusted size of USD 22110 million by 2028 with a CAGR of 14.3% during review period. Hospital Pharmacy accounting for % of the Biosimilar global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biosimilar include AET BioTech, Amgen, Boehringer Ingelheim, Coherus Biosciences, and Fujifilm Kyowa Kirin Biologics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilar market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Oral Solution
Market segment by Application, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market segment by players, this report covers
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar, with revenue, gross margin and global market share of Biosimilar from 2019 to 2022.
Chapter 3, the Biosimilar competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilar market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilar research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Biosimilar
1.2 Classification of Biosimilar by Type
1.2.1 Overview: Global Biosimilar Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biosimilar Revenue Market Share by Type in 2021
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Global Biosimilar Market by Application
1.3.1 Overview: Global Biosimilar Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Biosimilar Market Size & Forecast
1.5 Global Biosimilar Market Size and Forecast by Region
1.5.1 Global Biosimilar Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biosimilar Market Size by Region, (2017-2022)
1.5.3 North America Biosimilar Market Size and Prospect (2017-2028)
1.5.4 Europe Biosimilar Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biosimilar Market Size and Prospect (2017-2028)
1.5.6 South America Biosimilar Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biosimilar Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilar Market Drivers
1.6.2 Biosimilar Market Restraints
1.6.3 Biosimilar Trends Analysis
2 Company Profiles
2.1 AET BioTech
2.1.1 AET BioTech Details
2.1.2 AET BioTech Major Business
2.1.3 AET BioTech Biosimilar Product and Solutions
2.1.4 AET BioTech Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AET BioTech Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biosimilar Product and Solutions
2.2.4 Amgen Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Biosimilar Product and Solutions
2.3.4 Boehringer Ingelheim Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Coherus Biosciences
2.4.1 Coherus Biosciences Details
2.4.2 Coherus Biosciences Major Business
2.4.3 Coherus Biosciences Biosimilar Product and Solutions
2.4.4 Coherus Biosciences Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Coherus Biosciences Recent Developments and Future Plans
2.5 Fujifilm Kyowa Kirin Biologics
2.5.1 Fujifilm Kyowa Kirin Biologics Details
2.5.2 Fujifilm Kyowa Kirin Biologics Major Business
2.5.3 Fujifilm Kyowa Kirin Biologics Biosimilar Product and Solutions
2.5.4 Fujifilm Kyowa Kirin Biologics Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Fujifilm Kyowa Kirin Biologics Recent Developments and Future Plans
2.6 LG Life Sciences/Mochida Pharmaceutical
2.6.1 LG Life Sciences/Mochida Pharmaceutical Details
2.6.2 LG Life Sciences/Mochida Pharmaceutical Major Business
2.6.3 LG Life Sciences/Mochida Pharmaceutical Biosimilar Product and Solutions
2.6.4 LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 LG Life Sciences/Mochida Pharmaceutical Recent Developments and Future Plans
2.7 Momenta Pharmaceuticals
2.7.1 Momenta Pharmaceuticals Details
2.7.2 Momenta Pharmaceuticals Major Business
2.7.3 Momenta Pharmaceuticals Biosimilar Product and Solutions
2.7.4 Momenta Pharmaceuticals Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Momenta Pharmaceuticals Recent Developments and Future Plans
2.8 Oncobiologics
2.8.1 Oncobiologics Details
2.8.2 Oncobiologics Major Business
2.8.3 Oncobiologics Biosimilar Product and Solutions
2.8.4 Oncobiologics Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Oncobiologics Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Biosimilar Product and Solutions
2.9.4 Pfizer Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Samsung Bioepsis
2.10.1 Samsung Bioepsis Details
2.10.2 Samsung Bioepsis Major Business
2.10.3 Samsung Bioepsis Biosimilar Product and Solutions
2.10.4 Samsung Bioepsis Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Samsung Bioepsis Recent Developments and Future Plans
2.11 Sandoz
2.11.1 Sandoz Details
2.11.2 Sandoz Major Business
2.11.3 Sandoz Biosimilar Product and Solutions
2.11.4 Sandoz Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sandoz Recent Developments and Future Plans
2.12 Zydus Cadila
2.12.1 Zydus Cadila Details
2.12.2 Zydus Cadila Major Business
2.12.3 Zydus Cadila Biosimilar Product and Solutions
2.12.4 Zydus Cadila Biosimilar Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Zydus Cadila Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosimilar Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biosimilar Players Market Share in 2021
3.2.2 Top 10 Biosimilar Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biosimilar Players Head Office, Products and Services Provided
3.4 Biosimilar Mergers & Acquisitions
3.5 Biosimilar New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biosimilar Revenue and Market Share by Type (2017-2022)
4.2 Global Biosimilar Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biosimilar Revenue Market Share by Application (2017-2022)
5.2 Global Biosimilar Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biosimilar Revenue by Type (2017-2028)
6.2 North America Biosimilar Revenue by Application (2017-2028)
6.3 North America Biosimilar Market Size by Country
6.3.1 North America Biosimilar Revenue by Country (2017-2028)
6.3.2 United States Biosimilar Market Size and Forecast (2017-2028)
6.3.3 Canada Biosimilar Market Size and Forecast (2017-2028)
6.3.4 Mexico Biosimilar Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biosimilar Revenue by Type (2017-2028)
7.2 Europe Biosimilar Revenue by Application (2017-2028)
7.3 Europe Biosimilar Market Size by Country
7.3.1 Europe Biosimilar Revenue by Country (2017-2028)
7.3.2 Germany Biosimilar Market Size and Forecast (2017-2028)
7.3.3 France Biosimilar Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biosimilar Market Size and Forecast (2017-2028)
7.3.5 Russia Biosimilar Market Size and Forecast (2017-2028)
7.3.6 Italy Biosimilar Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biosimilar Revenue by Type (2017-2028)
8.2 Asia-Pacific Biosimilar Revenue by Application (2017-2028)
8.3 Asia-Pacific Biosimilar Market Size by Region
8.3.1 Asia-Pacific Biosimilar Revenue by Region (2017-2028)
8.3.2 China Biosimilar Market Size and Forecast (2017-2028)
8.3.3 Japan Biosimilar Market Size and Forecast (2017-2028)
8.3.4 South Korea Biosimilar Market Size and Forecast (2017-2028)
8.3.5 India Biosimilar Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biosimilar Market Size and Forecast (2017-2028)
8.3.7 Australia Biosimilar Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biosimilar Revenue by Type (2017-2028)
9.2 South America Biosimilar Revenue by Application (2017-2028)
9.3 South America Biosimilar Market Size by Country
9.3.1 South America Biosimilar Revenue by Country (2017-2028)
9.3.2 Brazil Biosimilar Market Size and Forecast (2017-2028)
9.3.3 Argentina Biosimilar Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biosimilar Revenue by Type (2017-2028)
10.2 Middle East & Africa Biosimilar Revenue by Application (2017-2028)
10.3 Middle East & Africa Biosimilar Market Size by Country
10.3.1 Middle East & Africa Biosimilar Revenue by Country (2017-2028)
10.3.2 Turkey Biosimilar Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biosimilar Market Size and Forecast (2017-2028)
10.3.4 UAE Biosimilar Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Biosimilar Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biosimilar Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biosimilar Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biosimilar Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biosimilar Revenue Market Share by Region (2023-2028)
Table 6. AET BioTech Corporate Information, Head Office, and Major Competitors
Table 7. AET BioTech Major Business
Table 8. AET BioTech Biosimilar Product and Solutions
Table 9. AET BioTech Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Biosimilar Product and Solutions
Table 13. Amgen Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim Major Business
Table 16. Boehringer Ingelheim Biosimilar Product and Solutions
Table 17. Boehringer Ingelheim Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Coherus Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. Coherus Biosciences Major Business
Table 20. Coherus Biosciences Biosimilar Product and Solutions
Table 21. Coherus Biosciences Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Fujifilm Kyowa Kirin Biologics Corporate Information, Head Office, and Major Competitors
Table 23. Fujifilm Kyowa Kirin Biologics Major Business
Table 24. Fujifilm Kyowa Kirin Biologics Biosimilar Product and Solutions
Table 25. Fujifilm Kyowa Kirin Biologics Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. LG Life Sciences/Mochida Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 27. LG Life Sciences/Mochida Pharmaceutical Major Business
Table 28. LG Life Sciences/Mochida Pharmaceutical Biosimilar Product and Solutions
Table 29. LG Life Sciences/Mochida Pharmaceutical Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Momenta Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. Momenta Pharmaceuticals Major Business
Table 32. Momenta Pharmaceuticals Biosimilar Product and Solutions
Table 33. Momenta Pharmaceuticals Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Oncobiologics Corporate Information, Head Office, and Major Competitors
Table 35. Oncobiologics Major Business
Table 36. Oncobiologics Biosimilar Product and Solutions
Table 37. Oncobiologics Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Biosimilar Product and Solutions
Table 41. Pfizer Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Samsung Bioepsis Corporate Information, Head Office, and Major Competitors
Table 43. Samsung Bioepsis Major Business
Table 44. Samsung Bioepsis Biosimilar Product and Solutions
Table 45. Samsung Bioepsis Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sandoz Corporate Information, Head Office, and Major Competitors
Table 47. Sandoz Major Business
Table 48. Sandoz Biosimilar Product and Solutions
Table 49. Sandoz Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 51. Zydus Cadila Major Business
Table 52. Zydus Cadila Biosimilar Product and Solutions
Table 53. Zydus Cadila Biosimilar Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Biosimilar Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Biosimilar Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Biosimilar Players Head Office, Products and Services Provided
Table 58. Biosimilar Mergers & Acquisitions in the Past Five Years
Table 59. Biosimilar New Entrants and Expansion Plans
Table 60. Global Biosimilar Revenue (USD Million) by Type (2017-2022)
Table 61. Global Biosimilar Revenue Share by Type (2017-2022)
Table 62. Global Biosimilar Revenue Forecast by Type (2023-2028)
Table 63. Global Biosimilar Revenue by Application (2017-2022)
Table 64. Global Biosimilar Revenue Forecast by Application (2023-2028)
Table 65. North America Biosimilar Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Biosimilar Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Biosimilar Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Biosimilar Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Biosimilar Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Biosimilar Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Biosimilar Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Biosimilar Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Biosimilar Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Biosimilar Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Biosimilar Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Biosimilar Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Biosimilar Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Biosimilar Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Biosimilar Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Biosimilar Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Biosimilar Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Biosimilar Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Biosimilar Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Biosimilar Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Biosimilar Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Biosimilar Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Biosimilar Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Biosimilar Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Biosimilar Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Biosimilar Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Biosimilar Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biosimilar Picture
Figure 2. Global Biosimilar Revenue Market Share by Type in 2021
Figure 3. Tablet
Figure 4. Oral Solution
Figure 5. Biosimilar Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacy Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Online Pharmacy Picture
Figure 9. Global Biosimilar Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Biosimilar Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Biosimilar Revenue Market Share by Region (2017-2028)
Figure 12. Global Biosimilar Revenue Market Share by Region in 2021
Figure 13. North America Biosimilar Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Biosimilar Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Biosimilar Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Biosimilar Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Biosimilar Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Biosimilar Market Drivers
Figure 19. Biosimilar Market Restraints
Figure 20. Biosimilar Market Trends
Figure 21. AET BioTech Recent Developments and Future Plans
Figure 22. Amgen Recent Developments and Future Plans
Figure 23. Boehringer Ingelheim Recent Developments and Future Plans
Figure 24. Coherus Biosciences Recent Developments and Future Plans
Figure 25. Fujifilm Kyowa Kirin Biologics Recent Developments and Future Plans
Figure 26. LG Life Sciences/Mochida Pharmaceutical Recent Developments and Future Plans
Figure 27. Momenta Pharmaceuticals Recent Developments and Future Plans
Figure 28. Oncobiologics Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Samsung Bioepsis Recent Developments and Future Plans
Figure 31. Sandoz Recent Developments and Future Plans
Figure 32. Zydus Cadila Recent Developments and Future Plans
Figure 33. Global Biosimilar Revenue Share by Players in 2021
Figure 34. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Biosimilar Revenue Market Share in 2021
Figure 36. Global Top 10 Players Biosimilar Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Biosimilar Revenue Share by Type in 2021
Figure 39. Global Biosimilar Market Share Forecast by Type (2023-2028)
Figure 40. Global Biosimilar Revenue Share by Application in 2021
Figure 41. Global Biosimilar Market Share Forecast by Application (2023-2028)
Figure 42. North America Biosimilar Sales Market Share by Type (2017-2028)
Figure 43. North America Biosimilar Sales Market Share by Application (2017-2028)
Figure 44. North America Biosimilar Revenue Market Share by Country (2017-2028)
Figure 45. United States Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Biosimilar Sales Market Share by Type (2017-2028)
Figure 49. Europe Biosimilar Sales Market Share by Application (2017-2028)
Figure 50. Europe Biosimilar Revenue Market Share by Country (2017-2028)
Figure 51. Germany Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Biosimilar Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Biosimilar Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Biosimilar Revenue Market Share by Region (2017-2028)
Figure 59. China Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Biosimilar Sales Market Share by Type (2017-2028)
Figure 66. South America Biosimilar Sales Market Share by Application (2017-2028)
Figure 67. South America Biosimilar Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Biosimilar Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Biosimilar Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Biosimilar Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Biosimilar Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
